Ocadlikova D. CO45 | Targeting IDO1 and ATP catabolism overcomes the tolerogenic effects of cytarabine on acute myeloid leukemia immune microenvironment: <a href="https://haematologica.org/search/search?query=D.+Ocadlikova">D. Ocadlikova</a>1, <a href="https://haematologica.org/search/search?query=P.+Portararo">P. Portararo</a>2, <a href="https://haematologica.org/search/search?query=E.+Adinolfi">E. Adinolfi</a>3, <a href="https://haematologica.org/search/search?query=E.+De+Marchi">E. De Marchi</a>3, <a href="https://haematologica.org/search/search?query=A.+Pegoraro">A. Pegoraro</a>3, <a href="https://haematologica.org/search/search?query=E.+Orioli">E. Orioli</a>3, <a href="https://haematologica.org/search/search?query=S.+Sangaletti">S. Sangaletti</a>2, <a href="https://haematologica.org/search/search?query=A.+Curti">A. Curti</a>1 | 1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”; 2Fondazione IRCCS, Istituto Nazionale dei Tumori; 3Department of Medical Sciences, University of Ferrara, Italy.. haematol [Internet]. 2026Mar.3 [cited 2026Mar.4];111(s1). Available from: https://haematologica.org/article/view/haematol.2026.s1.49